Alfred Uppal

PHD Doctor of Philosophy,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Career Advice and Mentoring Grant Submission IT-Web-Mobile Technology Data Science-Bioinformatics Scientific Writing

Areas Of Interest

Wages Agents, Antipsychotic Sound, Respiratory Diphosphonates Coding Regions, Protein Receptors, Vasoactive Intestinal Peptide Roseolovirus Infection Habenulas Leukocyte Differentiation Antigens, Human Size, Mitochondria Emodin, Rheum Phaeohyphomycosis, Cutaneous Delusional Parasitosis Packs, Mud Hand Joints Neoplasm, Hematologic Catenins Corpus Trapezoideums Insulin-Like Growth Factor Binding Protein 8 Parahippocampal Gyri, Posterior Hemangioma, Intracerebral Cavernous Central Retinal Artery Lauric Acid Hydroxylase parechovirus, Human Radiology, Diagnostic X-Ray Group III Secretory Phospholipase A2 Coumarones Encephalocele, Frontal Phosphate, Erythromycin Arachidonic Acid 15 Lipoxygenase Smooth Muscle Cell Government Employees Feeder Layer Cells MMP 8 Metalloproteinase Comprehensive Health Insurances Rheumatic Arthritis Negative-Pressure Dressing Aldosterone Receptor Antagonists Physical Micro Trauma

Professional Narrative

Dr. Alfred Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 2013
Assistant Professor, Amgen 1995

Education

Director Medicine, Harvard Medical School 2001
Doctor of medicine, Baylor College 2005

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :